Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

14.90
Delayed Data
As of Dec 09
 +0.40 / +2.76%
Today’s Change
7.86
Today|||52-Week Range
16.95
+0.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues22.4M19.9M26.4M29.1M
 
 
 
 
 
Depreciation And Amortization2.1M2.2M2.5M2.3M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses49.9M42.3M45.5M45.1M
 
 
 
 
 
Research And Development37.6M28.8M33.2M31.6M
 
 
 
 
 
Total Operating Expenses51.9M44.4M48.1M47.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-29.5M-24.6M-21.6M-18.2M
 
 
 
 
 
Other Expenses62.0K62.0K62.0K38.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.2M-24.0M-21.0M-17.5M
 
 
 
 
 
Net Income-29.2M-24.0M-21.0M-17.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS68.1M68.3M68.5M68.8M
 
 
 
 
 
Shares To Calculate EPS Diluted68.1M68.3M68.5M68.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.43-$0.35-$0.31-$0.26
 
 
 
 
 
EPS Diluted-$0.43-$0.35-$0.31-$0.26